BioNTech testing vaccine against new UK variant

Preparations for the roll-out come as the identification of a highly infectious new strain of the coronavirus in Britain causes chaos across the region, with countries shutting off travel ties with the United Kingdom and disrupting trade ahead of the

Christmas holiday.

BioNTech Chief Executive Ugur Sahin said the company is testing whether the vaccine is effective against the variant strain and expects results in the next two weeks.

"There is no reason to be concerned or worried until we get the data," he said.